Trial Outcomes & Findings for Coaching for HCV and HIV (NCT NCT04314414)

NCT ID: NCT04314414

Last Updated: 2022-12-19

Results Overview

As part of an investigator developed survey a 5-point LIkert scale question will be asked on how acceptable the intervention/care was where 1 is not acceptable and 5 is very acceptable.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

31 participants

Primary outcome timeframe

6 months

Results posted on

2022-12-19

Participant Flow

Participant milestones

Participant milestones
Measure
Intervention Group
Participants in the intervention group will receive a semi-scripted brief motivational interview from the peer recovery coach (PRC) in addition to the standard of care at Boston Medical Center (BMC) for HIV, hepatitis C (HCV), and opioid use disorder. PRC brief motivational interview intervention: The intervention will involve the following elements: establishing rapport, asking permission to discuss drugs, discussing the pros and cons associated with drug use, uncovering the gaps between current and desired quality of life and determining readiness to change. The intervention will last approximately 20 minutes and take place at the time of the clinical visit while participants are waiting to be seen by a clinician or are awaiting laboratory testing. Phone contact: The PRC will remain in at least weekly contact by phone with each participant.
3 Months
STARTED
31
3 Months
COMPLETED
31
3 Months
NOT COMPLETED
0
6 Months
STARTED
31
6 Months
COMPLETED
29
6 Months
NOT COMPLETED
2

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Coaching for HCV and HIV

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Intervention Group
n=31 Participants
Participants in the intervention group will receive a semi-scripted brief motivational interview from the peer recovery coach (PRC) in addition to the standard of care at Boston Medical Center (BMC) for HIV, HCV, and opioid use disorder. PRC brief motivational interview intervention: The intervention will involve the following elements: establishing rapport, asking permission to discuss drugs, discussing the pros and cons associated with drug use, uncovering the gaps between current and desired quality of life and determining readiness to change. The intervention will last approximately 20 minutes and take place at the time of the clinical visit while participants are waiting to be seen by a clinician or are awaiting laboratory testing. Phone contact: The PRC will remain in at least weekly contact by phone with each participant.
Age, Categorical
<=18 years
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
31 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
Sex: Female, Male
Female
10 Participants
n=5 Participants
Sex: Female, Male
Male
21 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
8 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
23 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
Race/Ethnicity, Customized
How would you describe your racial/ethnic identity? (check all that apply) · American Indian or Alaska Native
2 Participants
n=5 Participants
Race/Ethnicity, Customized
How would you describe your racial/ethnic identity? (check all that apply) · Asian
0 Participants
n=5 Participants
Race/Ethnicity, Customized
How would you describe your racial/ethnic identity? (check all that apply) · Black or African American
3 Participants
n=5 Participants
Race/Ethnicity, Customized
How would you describe your racial/ethnic identity? (check all that apply) · Native Hawaiian or Pacific Islander
1 Participants
n=5 Participants
Race/Ethnicity, Customized
How would you describe your racial/ethnic identity? (check all that apply) · Hispanic/Latinx
8 Participants
n=5 Participants
Race/Ethnicity, Customized
How would you describe your racial/ethnic identity? (check all that apply) · White
17 Participants
n=5 Participants
Region of Enrollment
United States
31 participants
n=5 Participants

PRIMARY outcome

Timeframe: 6 months

Population: 20 out of the 29 participants that were retained at 6 months, completed the 6 month satisfaction survey. 9 Participants were unreachable at 6 months. Only 14 participants were asked about the cell phones as it was added later in the study.

As part of an investigator developed survey a 5-point LIkert scale question will be asked on how acceptable the intervention/care was where 1 is not acceptable and 5 is very acceptable.

Outcome measures

Outcome measures
Measure
Intervention Group
n=29 Participants
Participants in the intervention group will receive a semi-scripted brief motivational interview from the peer recovery coach (PRC) in addition to the standard of care at Boston Medical Center (BMC) for HIV, HCV, and opioid use disorder. PRC brief motivational interview intervention: The intervention will involve the following elements: establishing rapport, asking permission to discuss drugs, discussing the pros and cons associated with drug use, uncovering the gaps between current and desired quality of life and determining readiness to change. The intervention will last approximately 20 minutes and take place at the time of the clinical visit while participants are waiting to be seen by a clinician or are awaiting laboratory testing. Phone contact: The PRC will remain in at least weekly contact by phone with each participant.
Acceptability of Intervention
Satisfaction working with Peer Recovery Coach · Very Satisfied/Strongly Agreed
13 Participants
Acceptability of Intervention
Satisfaction working with Peer Recovery Coach · Satisfied/Agreed
6 Participants
Acceptability of Intervention
Satisfaction working with Peer Recovery Coach · Neither Satisfied nor Dissatisfied/NA
0 Participants
Acceptability of Intervention
Satisfaction working with Peer Recovery Coach · Dissatisfied/Disagreed
0 Participants
Acceptability of Intervention
Satisfaction working with Peer Recovery Coach · Very Dissatisfied/Strongly Disagreed
1 Participants
Acceptability of Intervention
Intervention was helpful · Very Satisfied/Strongly Agreed
16 Participants
Acceptability of Intervention
Intervention was helpful · Satisfied/Agreed
3 Participants
Acceptability of Intervention
Intervention was helpful · Neither Satisfied nor Dissatisfied/NA
1 Participants
Acceptability of Intervention
Intervention was helpful · Dissatisfied/Disagreed
0 Participants
Acceptability of Intervention
Intervention was helpful · Very Dissatisfied/Strongly Disagreed
0 Participants
Acceptability of Intervention
Peer Recovery Coach Provided Navigation to Substance Use Programs/Resources · Very Satisfied/Strongly Agreed
15 Participants
Acceptability of Intervention
Peer Recovery Coach Provided Navigation to Substance Use Programs/Resources · Satisfied/Agreed
4 Participants
Acceptability of Intervention
Peer Recovery Coach Provided Navigation to Substance Use Programs/Resources · Neither Satisfied nor Dissatisfied/NA
0 Participants
Acceptability of Intervention
Peer Recovery Coach Provided Navigation to Substance Use Programs/Resources · Dissatisfied/Disagreed
0 Participants
Acceptability of Intervention
Peer Recovery Coach Provided Navigation to Substance Use Programs/Resources · Very Dissatisfied/Strongly Disagreed
1 Participants
Acceptability of Intervention
Peer Recovery Coach Provided Access to HIV Prevention and PrEP · Very Satisfied/Strongly Agreed
12 Participants
Acceptability of Intervention
Peer Recovery Coach Provided Access to HIV Prevention and PrEP · Satisfied/Agreed
7 Participants
Acceptability of Intervention
Peer Recovery Coach Provided Access to HIV Prevention and PrEP · Neither Satisfied nor Dissatisfied/NA
1 Participants
Acceptability of Intervention
Peer Recovery Coach Provided Access to HIV Prevention and PrEP · Dissatisfied/Disagreed
0 Participants
Acceptability of Intervention
Peer Recovery Coach Provided Access to HIV Prevention and PrEP · Very Dissatisfied/Strongly Disagreed
0 Participants
Acceptability of Intervention
Helpfulness of Phone · Very Satisfied/Strongly Agreed
12 Participants
Acceptability of Intervention
Helpfulness of Phone · Satisfied/Agreed
2 Participants
Acceptability of Intervention
Helpfulness of Phone · Neither Satisfied nor Dissatisfied/NA
0 Participants
Acceptability of Intervention
Helpfulness of Phone · Dissatisfied/Disagreed
0 Participants
Acceptability of Intervention
Helpfulness of Phone · Very Dissatisfied/Strongly Disagreed
0 Participants
Acceptability of Intervention
Lived-Experience of Peer Recovery Had Positive Impact · Very Satisfied/Strongly Agreed
15 Participants
Acceptability of Intervention
Lived-Experience of Peer Recovery Had Positive Impact · Satisfied/Agreed
4 Participants
Acceptability of Intervention
Lived-Experience of Peer Recovery Had Positive Impact · Neither Satisfied nor Dissatisfied/NA
0 Participants
Acceptability of Intervention
Lived-Experience of Peer Recovery Had Positive Impact · Dissatisfied/Disagreed
0 Participants
Acceptability of Intervention
Lived-Experience of Peer Recovery Had Positive Impact · Very Dissatisfied/Strongly Disagreed
1 Participants

SECONDARY outcome

Timeframe: 3 months and 6 months

Population: At 3 months 31 participants retained in the study, but only 16 participants completed the 3 month satisfaction survey due to unable to contact all participants. At 6 months 29 participants retained in the study but only 20 completed the 6 month satisfaction survey due to unable to contact all participants.

Participants will be interviewed and asked investigator developed questions about linkage to HIV care

Outcome measures

Outcome measures
Measure
Intervention Group
n=31 Participants
Participants in the intervention group will receive a semi-scripted brief motivational interview from the peer recovery coach (PRC) in addition to the standard of care at Boston Medical Center (BMC) for HIV, HCV, and opioid use disorder. PRC brief motivational interview intervention: The intervention will involve the following elements: establishing rapport, asking permission to discuss drugs, discussing the pros and cons associated with drug use, uncovering the gaps between current and desired quality of life and determining readiness to change. The intervention will last approximately 20 minutes and take place at the time of the clinical visit while participants are waiting to be seen by a clinician or are awaiting laboratory testing. Phone contact: The PRC will remain in at least weekly contact by phone with each participant.
Participant Linkage to HIV Care
3 Months: PRC provided access to HIV prevention and PrEP. · Strongly Agree
9 Participants
Participant Linkage to HIV Care
3 Months: PRC provided access to HIV prevention and PrEP. · Agree
5 Participants
Participant Linkage to HIV Care
3 Months: PRC provided access to HIV prevention and PrEP. · Neither/Na
2 Participants
Participant Linkage to HIV Care
3 Months: PRC provided access to HIV prevention and PrEP. · Disagree
0 Participants
Participant Linkage to HIV Care
3 Months: PRC provided access to HIV prevention and PrEP. · Strongly
0 Participants
Participant Linkage to HIV Care
6 Months: PRC provided access to HIV prevention and PrEP. · Strongly Agree
12 Participants
Participant Linkage to HIV Care
6 Months: PRC provided access to HIV prevention and PrEP. · Agree
7 Participants
Participant Linkage to HIV Care
6 Months: PRC provided access to HIV prevention and PrEP. · Neither/Na
1 Participants
Participant Linkage to HIV Care
6 Months: PRC provided access to HIV prevention and PrEP. · Disagree
0 Participants
Participant Linkage to HIV Care
6 Months: PRC provided access to HIV prevention and PrEP. · Strongly
0 Participants

SECONDARY outcome

Timeframe: 6 months

Population: Only 9 participants were eligible for HCV treatment as they tested positive for HCV.

Participants will be interviewed and asked investigator developed questions about linkage to HCV care

Outcome measures

Outcome measures
Measure
Intervention Group
n=31 Participants
Participants in the intervention group will receive a semi-scripted brief motivational interview from the peer recovery coach (PRC) in addition to the standard of care at Boston Medical Center (BMC) for HIV, HCV, and opioid use disorder. PRC brief motivational interview intervention: The intervention will involve the following elements: establishing rapport, asking permission to discuss drugs, discussing the pros and cons associated with drug use, uncovering the gaps between current and desired quality of life and determining readiness to change. The intervention will last approximately 20 minutes and take place at the time of the clinical visit while participants are waiting to be seen by a clinician or are awaiting laboratory testing. Phone contact: The PRC will remain in at least weekly contact by phone with each participant.
Participant Linkage to HCV Care
Participants engaged in HCV treatment at time of enrollment.
0 Participants
Participant Linkage to HCV Care
Participants receiving or had completed HCV treatment at 6 months.
2 Participants

SECONDARY outcome

Timeframe: 3 months and 6 months

Population: At 3 months, not all participants were contactable. 16 participants out of 31 completed the satisfaction survey. At 6 months, not all participants were contactable. 20 participants out of 29 completed the satisfaction survey.

Participants will be interviewed and asked investigator developed questions about their linkage to care for opioid use

Outcome measures

Outcome measures
Measure
Intervention Group
n=31 Participants
Participants in the intervention group will receive a semi-scripted brief motivational interview from the peer recovery coach (PRC) in addition to the standard of care at Boston Medical Center (BMC) for HIV, HCV, and opioid use disorder. PRC brief motivational interview intervention: The intervention will involve the following elements: establishing rapport, asking permission to discuss drugs, discussing the pros and cons associated with drug use, uncovering the gaps between current and desired quality of life and determining readiness to change. The intervention will last approximately 20 minutes and take place at the time of the clinical visit while participants are waiting to be seen by a clinician or are awaiting laboratory testing. Phone contact: The PRC will remain in at least weekly contact by phone with each participant.
Participant Linkage to Care for Opioid Use
6 Months: The PRC provided adequate navigation to substance use programs and/or resources. · Neither or N/A
0 Participants
Participant Linkage to Care for Opioid Use
6 Months: The PRC provided adequate navigation to substance use programs and/or resources. · Disagree
1 Participants
Participant Linkage to Care for Opioid Use
6 Months: The PRC provided adequate navigation to substance use programs and/or resources. · Strongly Disagree
0 Participants
Participant Linkage to Care for Opioid Use
3 Months: The PRC provided adequate navigation to substance use programs and/or resources. · Strongly Agree
10 Participants
Participant Linkage to Care for Opioid Use
3 Months: The PRC provided adequate navigation to substance use programs and/or resources. · Agree
6 Participants
Participant Linkage to Care for Opioid Use
3 Months: The PRC provided adequate navigation to substance use programs and/or resources. · Neither or N/A
0 Participants
Participant Linkage to Care for Opioid Use
3 Months: The PRC provided adequate navigation to substance use programs and/or resources. · Disagree
0 Participants
Participant Linkage to Care for Opioid Use
3 Months: The PRC provided adequate navigation to substance use programs and/or resources. · Strongly Disagree
0 Participants
Participant Linkage to Care for Opioid Use
6 Months: The PRC provided adequate navigation to substance use programs and/or resources. · Strongly Agree
15 Participants
Participant Linkage to Care for Opioid Use
6 Months: The PRC provided adequate navigation to substance use programs and/or resources. · Agree
4 Participants

SECONDARY outcome

Timeframe: 6 months

Population: Of all 29 participants at 6 months, only 14 were eligible to initiate PrEP.

Whether participants received PrEp treatment will be abstracted from their electronic medical records (EMR) system.

Outcome measures

Outcome measures
Measure
Intervention Group
n=29 Participants
Participants in the intervention group will receive a semi-scripted brief motivational interview from the peer recovery coach (PRC) in addition to the standard of care at Boston Medical Center (BMC) for HIV, HCV, and opioid use disorder. PRC brief motivational interview intervention: The intervention will involve the following elements: establishing rapport, asking permission to discuss drugs, discussing the pros and cons associated with drug use, uncovering the gaps between current and desired quality of life and determining readiness to change. The intervention will last approximately 20 minutes and take place at the time of the clinical visit while participants are waiting to be seen by a clinician or are awaiting laboratory testing. Phone contact: The PRC will remain in at least weekly contact by phone with each participant.
Number of Participants Who Received Pre-exposure Prophylaxis (PrEP)
Number of participants that started PrEP during the intervention
5 Participants
Number of Participants Who Received Pre-exposure Prophylaxis (PrEP)
Number of participants on PrEP at 6 months
6 Participants

SECONDARY outcome

Timeframe: 6 months

Population: Only 9 participants were eligible for HCV as they tested positive.

Whether participants received HCV care will be abstracted from their electronic medical records (EMR) system.

Outcome measures

Outcome measures
Measure
Intervention Group
n=9 Participants
Participants in the intervention group will receive a semi-scripted brief motivational interview from the peer recovery coach (PRC) in addition to the standard of care at Boston Medical Center (BMC) for HIV, HCV, and opioid use disorder. PRC brief motivational interview intervention: The intervention will involve the following elements: establishing rapport, asking permission to discuss drugs, discussing the pros and cons associated with drug use, uncovering the gaps between current and desired quality of life and determining readiness to change. The intervention will last approximately 20 minutes and take place at the time of the clinical visit while participants are waiting to be seen by a clinician or are awaiting laboratory testing. Phone contact: The PRC will remain in at least weekly contact by phone with each participant.
Number of Participants Who Received HCV Care
Number of participants engaged in HCV treatment at the time of enrollment
0 Participants
Number of Participants Who Received HCV Care
Number of participants receiving or had completed HCV treatment at 6 months.
2 Participants

SECONDARY outcome

Timeframe: 6 months

Population: 22 participants were already on a medications for opioid use disorder (MOUD) before enrollment. Of the total number of participants analyzed, 6 started a MOUD on the day of the enrollment.

Whether participants received opioid use treatment will be abstracted from their electronic medical records (EMR) system.

Outcome measures

Outcome measures
Measure
Intervention Group
n=31 Participants
Participants in the intervention group will receive a semi-scripted brief motivational interview from the peer recovery coach (PRC) in addition to the standard of care at Boston Medical Center (BMC) for HIV, HCV, and opioid use disorder. PRC brief motivational interview intervention: The intervention will involve the following elements: establishing rapport, asking permission to discuss drugs, discussing the pros and cons associated with drug use, uncovering the gaps between current and desired quality of life and determining readiness to change. The intervention will last approximately 20 minutes and take place at the time of the clinical visit while participants are waiting to be seen by a clinician or are awaiting laboratory testing. Phone contact: The PRC will remain in at least weekly contact by phone with each participant.
Number of Participants Who Received Opioid Use Treatment
Number of participants who were on MOUD at the time of enrollment.
22 Participants
Number of Participants Who Received Opioid Use Treatment
Number of participants that started MOUD on the day of enrollment.
6 Participants
Number of Participants Who Received Opioid Use Treatment
Number of participants on MOUD at 6 months after enrollment
15 Participants
Number of Participants Who Received Opioid Use Treatment
Number of participants on MOUD at enrollment and remained on through the end of the intervention
13 Participants

Adverse Events

Intervention Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Sabrina A Assoumou, MD MPH

Boston Medical Center

Phone: (617) 414-5282

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place